Switching should not be driven by price alone clinical suitability, tolerability and patient preference remain paramount
Lion's mane trials typically run 816 weeks at 1,0003,000 mg/day (PubMed), and reishi and cordyceps studies use comparable ranges
John Myers, a family and obesity medicine physician at Baylor Scott and White, said the lack of clinical data is what keeps him from recommending unapproved peptides to patients
Healthcare providers should consider renal function, gastrointestinal tolerability, and cardiovascular risk profile when selecting the most appropriate agent
Jastreboff AM, Ryan DH, Bays HE, Ebeling PR, Mackowski MG, Philipose N, Ross L, Liu Y, Burns CE, Abbasi SA, Pannacciulli N